Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Morris

Showing results (191-200 of 196) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 196 results.
British Journal of Cancer|October 9, 2008
Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancerP Mathew, P F Thall, S Wen, et al.
JMIR Research Protocols|March 18, 2024
Group Acceptance and Commitment Therapy for Recovery From Psychosis: Protocol for a Single-Group Waitlist TrialMarilyn L Cugnetto, Eric M J Morris, Siobain F Bonfield, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2025
Final overall survival and safety analyses of the phase III PSMAfore trial of [<sup>177</sup>Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancerK Fizazi, K N Chi, N D Shore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2020
Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancerS Halabi, S Dutta, C M Tangen, et al.
Journal of Developmental Origins of Health and Disease|October 1, 2016
A review of fundamental principles for animal models of DOHaD research: an Australian perspectiveH Dickinson, T J Moss, K L Gatford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2017
Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweetA J Armstrong, E S Antonarakis, M-E Taplin, et al.
Pageof 20

Showing results (191-200 of 196) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 196 results.
British Journal of Cancer|October 9, 2008
Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancerP Mathew, P F Thall, S Wen, et al.
JMIR Research Protocols|March 18, 2024
Group Acceptance and Commitment Therapy for Recovery From Psychosis: Protocol for a Single-Group Waitlist TrialMarilyn L Cugnetto, Eric M J Morris, Siobain F Bonfield, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2025
Final overall survival and safety analyses of the phase III PSMAfore trial of [<sup>177</sup>Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancerK Fizazi, K N Chi, N D Shore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2020
Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancerS Halabi, S Dutta, C M Tangen, et al.
Journal of Developmental Origins of Health and Disease|October 1, 2016
A review of fundamental principles for animal models of DOHaD research: an Australian perspectiveH Dickinson, T J Moss, K L Gatford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2017
Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweetA J Armstrong, E S Antonarakis, M-E Taplin, et al.
Pageof 20